| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |